Code | 49624 | ||||||||||
MA number | 31/0116/08-S | ||||||||||
Product Form: | cps dur 60x267 mg | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 26.03.2008 |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Fenofibrate Teva 267 mg_07/2020.doc |
PIL: | PIL_Fenofibrate Teva 267 mg_03.2021.doc |
Safety feature | Yes |
Data update: | 13.11.2019 |